Browsing: speslimab

Spesolimab approved in Malaysia for the treatment of Generalized Pustular Psoriasis flares in adults

By Boehringer IngelheimDecember 13, 20240

The National Pharmaceutical Regulatory Agency (NPRA) Malaysia has approved Spesolimab (marketed as SPEVIGO®) for the treatment of flares in adults with generalized pustular psoriasis (GPP), the first indicated treatment of its kind in Malaysia.

About
Advertise
Contact Us
Privacy Policy

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Duke-NUS and T Cells Diagnostics team up to simplify T-cell analysis

Malaysia’s Next Drug Threat: The Rise of Fentanyl

Teen from RGS Resuscitates Tourist at Novena with CPR, Helps Save Life

Browsing: speslimab

Spesolimab approved in Malaysia for the treatment of Generalized Pustular Psoriasis flares in adults

Duke-NUS and T Cells Diagnostics team up to simplify T-cell analysis

Malaysia’s Next Drug Threat: The Rise of Fentanyl

Teen from RGS Resuscitates Tourist at Novena with CPR, Helps Save Life

Why Pregnant Women Crave the Strangest Foods

Subscribe to Updates

What's Hot

Browsing: speslimab

Subscribe to Updates